On August 10, 2022, Kevin Farr was terminated without cause as Chief Financial Officer of ChromaDex Corporation and as an officer, employee, and director of the Company and any subsidiaries of the Company in which he serves in any of those capacities, effective as of August 12, 2022. On August 10, 2022, the Board of Directors of ChromaDex (the Board") appointed Brianna Gerber as SVP, Finance /Interim Chief Financial Officer, effective as of August 11, 2022, to replace the vacancy created by Mr. Farr's termination as disclosed in item (a) above. Ms. Gerber, age 42, previously served as Vice President of Finance and Investor Relations of ChromaDex Inc. since September 17, 2018, and prior to that served in multiple leadership roles at Mattel Inc. since 2013. Ms. Gerber received her B.S. in Corporate Finance and Entrepreneurship from the University of Southern
California. She is a Chartered Financial Analyst (CFA) and member of the CFA Society of Los Angeles. In On August 8, 2022, the Board appointed Hamed Shahbazi as a member of the Board effective as of August 9, 2022,
to serve until the Company's 2023 annual meeting of stockholders and until his successor is duly elected and qualified. Mr. Shahbazi, 47, serves as Chief Executive Officer and Chairman of the Board at WELL Health
Technologies Corp. Prior to this, he spent twenty years as Chief Executive Officer at TIO Networks Corp. where he also served as Chairman of the Board. Mr. Shahbazi has been appointed to the Nominating and Corporate Governance Committee of the Board. The Board has determined that Mr. Shahbazi is an independent director under the listing standards of the Nasdaq Stock Market LLC and is independent" as defined in 5605(a)(2) of the Securities Exchange Act of 1934, as amended.